By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nordic Nanovector 

Kjelsåsveien 168 B

  Oslo  0884  Norway
Phone: 47-22-18-33-01 Fax: 47-22-58-00-07


Company News
Nordic Nanovector And Heidelberg Pharma Enter Collaboration To Develop Novel Antibody-Drug Conjugates (ADCs) Targeting Leukaemias 10/26/2016 9:01:53 AM
Nordic Nanovector Announces The Appointment Of Joanna Horobin, MD As Non-Executive Board Director 10/12/2016 11:31:36 AM
Nordic Nanovector: Extraordinary General Meeting Held 10/12/2016 10:13:09 AM
Nordic Nanovector And LegoChem Biosciences Enter Collaboration To Develop Novel Antibody-Drug Conjugates (ADCS) Targeting Leukemias 10/10/2016 11:18:45 AM
Nordic Nanovector – Changes To The Board Of Directors And Notice Of Extraordinary General Meeting 9/21/2016 11:01:14 AM
Nordic Nanovector – Notification Of Share Capital Increase 9/13/2016 10:43:38 AM
Nordic Nanovector: Lilotomab Pre-Dosing Of NHL Patients Before Betalutin Therapy Lowers Hematological Toxicity With No Reduction In The Tumor Absorbed Radiation Dose 9/6/2016 11:48:20 AM
Nordic Nanovector - Financial Calendar 8/31/2016 10:39:53 AM
Nordic Nanovector — Results For Second Quarter And Half Year 2016 8/24/2016 9:09:06 AM
Nordic Nanovector Completes Recruitment Of The First Cohorts Of Arm 3 And Arm 4 Of Expanded Phase 1/2 Study Of Betalutin In NHL Patients 8/18/2016 8:38:03 AM